Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China.
This article urges availability of clinical study results of GSP tablet that would allow in-depth evaluation if the tablet is appropriate to serve as an immunomodulatory drug during cancer therapy at world stage.
PMID: 29078264 [PubMed - as supplied by publisher]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Jiang Y, Chang Y, Liu Y, Zhang M, Luo H, Hao C, Zeng P, Sun Y, Wang H, Zhang L Tags: Biomed Pharmacother Source Type: research
More News: Antidoxidants | Cancer | Cancer & Oncology | Cancer Therapy | China Health | Databases & Libraries | Drugs & Pharmacology | Food and Drug Administration (FDA) | Ganoderma | Mushrooms | Poisoning | Radiation Therapy | Study